KA Kreuzer and P le Coutre (2004) “Re: Lange T et al. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. Leukemia 2004; 89: 49-57”, Haematologica. Pavia, Italy, 89(8), pp. ELT12-ELT12. doi: 10.3324/%x.